| scholarly article | Q13442814 |
| P50 | author | Tracy D. Farr | Q48714570 |
| P2093 | author name string | M Sato | |
| I M Macrae | |||
| D J McCann | |||
| J A Dodge | |||
| H U Bryant | |||
| H V O Carswell | |||
| P2860 | cites work | Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial | Q28244429 |
| Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women | Q28251695 | ||
| The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women | Q29396434 | ||
| Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial | Q29615226 | ||
| Neuroprotective effects of female gonadal steroids in reproductively senescent female rats | Q30651308 | ||
| Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats | Q30653235 | ||
| 17beta-estradiol reduces stroke injury in estrogen-deficient female animals | Q30750600 | ||
| LY353381.HCl, a selective estrogen receptor modulator, and experimental stroke | Q30975956 | ||
| Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. | Q31134481 | ||
| Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats | Q31443527 | ||
| Estradiol protects against ischemic injury | Q31978205 | ||
| Estrogen-mediated neuroprotection after experimental stroke in male rats | Q32038461 | ||
| Estradiol protects against ischemic brain injury in middle-aged rats | Q34037103 | ||
| Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation | Q34191632 | ||
| Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance | Q34440772 | ||
| Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era. | Q35141438 | ||
| Stroke in the female: role of biological sex and estrogen | Q35757557 | ||
| Bench to bedside: the quest for quality in experimental stroke research | Q36416843 | ||
| Cortical infarct volume is dependent on the ischemic reduction of perifocal cerebral blood flow in a three-vessel intraluminal MCA occlusion/reperfusion model in the rat. | Q36847931 | ||
| A selective estrogen receptor modulator for the treatment of hot flushes. | Q40322311 | ||
| A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation | Q40400586 | ||
| Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats | Q42540641 | ||
| Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia | Q43590172 | ||
| Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: perfusion-dependent and-independent mechanisms | Q43854048 | ||
| Biomedicine. Defining the "S" in SERMs | Q43940266 | ||
| Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators | Q43988923 | ||
| Estrogen prevents the loss of CA1 hippocampal neurons in gerbils after ischemic injury | Q44306476 | ||
| 17beta-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats | Q44671982 | ||
| Differential effects of 17beta-estradiol upon stroke damage in stroke prone and normotensive rats | Q44848575 | ||
| Detrimental effects of 17beta-oestradiol after permanent middle cerebral artery occlusion | Q45221993 | ||
| Effects of 17beta-oestradiol on cerebral ischaemic damage and lipid peroxidation | Q45278320 | ||
| Estradiol increases brain lesions in the cortex and lateral striatum after transient occlusion of the middle cerebral artery in rats: no effect of ischemia on galanin in the stroke area but decreased levels in the hippocampus | Q46512438 | ||
| Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia | Q46627010 | ||
| Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety | Q48177746 | ||
| Effects of gender and estradiol treatment on focal brain ischemia | Q48481118 | ||
| Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex | Q48508648 | ||
| The effect of estrogens and antiestrogens in a rat model for hot flush. | Q51482151 | ||
| Similarities between morphine withdrawal in the rat and the menopausal hot flush. | Q52270638 | ||
| Tamoxifen and the endometrium: findings of pelvic ultrasound examination | Q58466203 | ||
| P433 | issue | 3 | |
| P921 | main subject | estrogen | Q277954 |
| P304 | page(s) | 366-374 | |
| P577 | publication date | 2008-01-15 | |
| P1433 | published in | Journal of Neuroendocrinology | Q3186929 |
| P1476 | title | The selective oestrogen receptor modulator, LY362321, is not neuroprotective in a rat model of transient focal ischaemia | |
| P478 | volume | 20 |
Search more.